Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Autophagy inhibition exacerbates adverse metabolic effects in non-lesional vitiligo cells Autophagy is an important cellular program with a potential double faced role that can promote either cell survival or cell death
In addition to JPH-203, other drugs currently in preclinical and clinical trials targeting LAT1 include IPA-131, QBS-10072S, TLX101-CDx, 124I-ACD-101, 211At-TLX-102, OKY-034, [18F] NKO-028 (Table 1)
For precise temperature thresholds and shelf-life guidance specific to this product, consult the CoA or contact Peptides World directly at (888) 442-2784 or via email during business hours (MondayFriday, 9AM4PM PST)
It is listed in the USFDAs GRAS list of safe food supplements
US$ 24.91
US$ 25.85
US$ 28.04
